Hairpin DNA-Based Nanomaterials for Tumor Targeting and Synergistic Therapy
DOI: https://doi.org/10.2147/ijn.s461774
IF: 7.033
2024-06-13
International Journal of Nanomedicine
Abstract:Lingling Shan, 1 Yudie Li, 1 Yifan Ma, 2 Yang Yang, 1 Jing Wang, 1 Lei Peng, 1 Weiwei Wang, 1 Fang Zhao, 1 Wanrong Li, 1 Xiaoyuan Chen 3– 6 1 Institute of Pharmaceutical Biotechnology, School of Biology and Food Engineering, Suzhou University, Suzhou, People's Republic of China; 2 Wuya College of Innovation, Shenyang Pharmaceutical University, Shenyang, People's Republic of China; 3 Departments of Diagnostic Radiology, Chemical and Biomolecular Engineering, and Biomedical Engineering, Yong Loo Lin School of Medicine and College of Design and Engineering, National University of Singapore, Singapore, Singapore; 4 Clinical Imaging Research Centre, Centre for Translational Medicine, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore; 5 Nanomedicine Translational Research Program, NUS Center for Nanomedicine, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore; 6 Institute of Molecular and Cell Biology, Agency for Science, Technology, and Research (A&astSTAR), Singapore, Singapore Correspondence: Xiaoyuan Chen; Lingling Shan, Email ; Background: While nanoplatform-based cancer theranostics have been researched and investigated for many years, enhancing antitumor efficacy and reducing toxic side effects is still an essential problem. Methods: We exploited nanoparticle coordination between ferric (Fe 2+ ) ions and telomerase-targeting hairpin DNA structures to encapsulate doxorubicin (DOX) and fabricated Fe 2+ -DNA@DOX nanoparticles (BDDF NPs). This work studied the NIR fluorescence imaging and pharmacokinetic studies targeting the ability and biodistribution of BDDF NPs. In vitro and vivo studies investigated the nano formula's toxicity, imaging, and synergistic therapeutic effects. Results: The enhanced permeability and retention (EPR) effect and tumor targeting resulted in prolonged blood circulation times and high tumor accumulation. Significantly, BDDF NPs could reduce DOX-mediated cardiac toxicity by improving the antioxidation ability of cardiomyocytes based on the different telomerase activities and iron dependency in normal and tumor cells. The synergistic treatment efficacy is enhanced through Fe 2+ -mediated ferroptosis and the β-catenin/p53 pathway and improved the tumor inhibition rate. Conclusion: Harpin DNA-based nanoplatforms demonstrated prolonged blood circulation, tumor drug accumulation via telomerase-targeting, and synergistic therapy to improve antitumor drug efficacy. Our work sheds new light on nanomaterials for future synergistic chemotherapy. Keywords: DNA nanomaterials, targeting, imaging, synergistic therapy Graphical An average of 13 nanomaterials have been approved for clinical antitumor therapy every five years since the mid-1990s. 1,2 This situation has extensively promoted the rapid development of nanomaterials. DNA nanostructures have the advantages of high programmability, addressability, modifiability, biocompatibility, and nontoxicity and have been widely used as drug delivery systems in treating malignant tumors. 3,4 However, multifunctional polymeric DNA nanodrug delivery systems have shortcomings in therapeutic applications, such as enzyme degradation, protein adsorption, and unclear metabolic pathways. 5,6 Therefore, numerous researchers have used combinations of DNA nanomaterials with other nanoparticles or polymer compounds, such as gold nanoparticles, 7 metal-organic frameworks (MOFs), 8 chitosan, 9 and polylysine, 10 to overcome the limitations of DNA nanomaterials. 11,12 As a result, the prepared DNA nanodrug delivery systems are polymers with complicated particle structures that are difficult to metabolize and have preparation and purification processes that are difficult to simplify. Since telomerase is specifically highly expressed in approximately 85% of tumor cells but poorly expressed in normal cells, it can target tumors. 13,14 Thus, telomerase-targeting DNA nanodrug delivery systems can be designed to load anticancer chemotherapy drugs and facilitate the recognition of tumor cells or tissues. A certain number of DNA fragments, such as 10–20 base DNA fragments, has recently been found to be rich in A/C base pairs and can form DNA nanostructures with ferric (Fe 2+ ) ions at high temperatures. 15,16 The preparation of these nanostructures requires a reaction at 95 °C for three hours. Reaction at high temperatures inevitably affects functional DNA activity and chemotherapy drug structure and fu -Abstract Truncated-
pharmacology & pharmacy,nanoscience & nanotechnology